secwatch.observer — SEC 8-K summary
======================================

Issuer:     MapLight Therapeutics, Inc. (MPLT)
CIK:        0001770069
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001193125-25-255041
Event type: other_material
Sentiment:  neutral
Materiality: 0.85
Item codes: 3.02, 8.01, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MapLight Therapeutics prices IPO at $17/sh, raises $296.3M including concurrent private placement
--------------------------------------------------------------------------------

- IPO of 14.75M shares at $17.00; underwriters fully exercise option for 2.2125M additional shares.
- Concurrent private placement to Goldman Sachs affiliates of 467,707 shares at same $17 price.
- Total gross proceeds of $296.3M before underwriting discounts, placement agent fees, and expenses.
- Amended and restated certificate of incorporation and bylaws effective upon IPO closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770069/000119312525255041/0001193125-25-255041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770069/000119312525255041/d89036d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-255041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer